Pharma-Bio Serv, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Victor Sanchez
- Full Time Employees
- 55
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- PO Box 1049 Dorado PR Puerto Rico 00646
- IPO Date
- May 7, 2007
- CIK
- 0001304161
- Website
- pharmabioserv.com
- Similar Companies
- Business
- Pharma-Bio Serv, Inc. (PBSV) provides integrated regulatory compliance, validation, technology transfer, and quality systems consulting services to highly regulated life sciences manufacturers. The company offers technical compliance consulting including regulatory affairs such as US agent services, establishment registrations, product listings, IND/NDA/BLA/ANDA filings, 510(k) and PMA packages, and post-approval supplements; commissioning, qualification and validation encompassing facilities/utilities/equipment qualification, risk assessments (FMEA, HAZOP), process validation (manufacturing, packaging, cleaning, sterility), computer system validation (21 CFR Part 11), analytical methods development, and capital project management; compliance and quality systems covering gap analyses, PAI readiness, remediation for FDA 483s/warning letters/consent decrees, SOP development, CAPA/change control/deviation management, stability programs, and supplier quality programs; data integrity evaluations and training/workshops on cGMP, regulatory topics (FDA/EMA/ANVISA), validation, human error, and CAPAs; as well as microbiological and chemical laboratory testing services through its Puerto Rico facility. It serves pharmaceutical, biotechnology, medical device, cosmetics, food, beverage, consumer products, and allied industries across more than 30 countries including Puerto Rico, the United States, Europe, Brazil, Canada, Mexico, India, Japan, and others. Founded in 1993 and headquartered in Dorado, Puerto Rico, Pharma-Bio Serv employs over 250 professionals and operates through segments in Puerto Rico technical compliance consulting, US consulting, Europe consulting, and Puerto Rico lab testing. The company reported a net loss of approximately $0.8 million for the fiscal year ended October 31, 2024, compared to prior net income, reflecting ongoing operational challenges amid its focus on expanding holistic service provision globally.
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026
Pharma-Bio Serv Announces Full Year Results and Special Dividend
Analyzing Pharma-Bio Serv (OTCMKTS:PBSV) and ATIF (NASDAQ:ZBAI)
ATIF (NASDAQ:ZBAI) and Pharma-Bio Serv (OTCMKTS:PBSV) Financial Analysis
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
Pharma-Bio Serv Announces Full Year Results
Pharma-Bio Serv Announces Special Dividend
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
Pharma-Bio Serv Announces Full Year Results
Pharma-Bio Serv Announces Special Dividend
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023
7 Best Penny Stocks Under $1 to Buy in July
7 Best Penny Stocks Under $1 to Buy Now
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021